top of page
Screenshot 2024-03-22 at 9.08.42 PM.png

HELPING YOU BUILD A BETTER TOMORROW

Sentinel Analytics LLC specializes in delivering scientific analysis that serves as a vital bridge between clinical experts and their financial counterparts

SET AN INTRODUCTION MEETING TODAY

Thanks for submitting!

ABOUT US

Our mission is to serve as a vital bridge between seasoned clinical experts and their financial counterparts

David Mangiameli II, the founder of Sentinel Analytics, has and continues to play a role in several medical systems across the world. David serves as a medic within the 106th Rescue Wing, one of the US Air Force’s designated search and rescue organizations. In this capacity, medics are trained in and provide a wide variety of medical services, from battlefield and prolonged critical care to outpatient flight medicine and everywhere in between. Additionally, he staffs several Emergency Service Agencies on Long Island, New York, and participates in volunteer medical missions on multiple continents. He is finalizing prerequisites necessary to attend medical school through Stony Brook University College of Health Sciences.

 

This exposure is uniquely beneficial when transitioning into the private sector, private equity arena, as there is extensive, active involvement in a wide variety of medical specialties. Further, the diversity of clinicians he encounters in practice proves to be advantageous when considering a variety of specialty specific factors. These elements, often unique to a field of medicine, play a large role in a multitude of facets determining the extent of a product's success, such as market penetration, clinical benefit, and present standards of care. 

 

Before founding Sentinel Analytics, David previously functioned as the sole scientific analyst for Forepont Capital Partners, based out of New York City. Throughout the life of the fund, the investment of ~$100M was supported by the composition of several investment memorandums, competition analysis papers, anatomic and technologic explication documents, substantiated by several interviews and consultations with key opinion leaders (KOLs) in their respective fields. The investments made under his guidance were widely successful, enabling the firm to begin to grow a fund multiple times its original size.

Sentinel ANalytics (3).png

WHAT WE CAN DO FOR YOU

Our office provides a multifaceted sound board for a variety of concerns pertaining to the evaluation of the MedTech company. Tailored to the needs of your firm, we provide information, analysis, and recommendations surrounding a number of industry specific factors including:

WE EVALUATE NUMEROUS FIELDS INCLUDING:

Sentinel ANalytics (4).png

Strong communication and understanding between the scientific and financial divisions of the due diligence process is crucial to making sound investment decisions. As a valuable intermediary between an MD/PhD and the VC/PE analyst, Sentinel Analytics LLC brings clarity and efficiency to what can be a complicated and risky undertaking. 

ENDOVASCULAR INSTRUMENTATION AND TECHNOLOGY

BRAIN COMPUTER INTERFACE

SMALL MOLECULE THERAPUTICS

BACTERIAL VACCINES

DIGITAL HEALTH AND SCREENING PRODUCTS

NEUROSTIMULATORS

AI-ENABLED DISEASE PREDICTIVE TECHNOLOGY

AI-ENABLED AUGMENTED RADIOLOGIC DIAGNOSTICS

MEDICAL LABORATORY TECHNOLOGY

REGENERATIVE MEDICINE WITHIN WOMEN'S HEALTH

NOVEL CANCER SCREENING PROTOCOLS

SPINAL CORD STIMULATORS

MICROBIOME MODULATION AS TREATMENT

ADOPTIVE CELL THERAPY (IMMUNOTHERAPY)

bottom of page